162 related articles for article (PubMed ID: 33731554)
21. Saving Lives: The Veterans Health Administration (VHA) Rapid Naloxone Initiative.
Oliva EM; Richardson J; Harvey MA; Bellino P
Jt Comm J Qual Patient Saf; 2021 Aug; 47(8):469-480. PubMed ID: 34330409
[TBL] [Abstract][Full Text] [Related]
22. Homelessness and Veteran Status in Relation to Nonfatal and Fatal Opioid Overdose in Massachusetts.
Jasuja GK; Bettano A; Smelson D; Bernson D; Rose AJ; Byrne T; Berlowitz DR; McCullough MB; Miller DR
Med Care; 2021 Apr; 59(Suppl 2):S165-S169. PubMed ID: 33710090
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of an Opiate Overdose Educational Intervention and Naloxone Prescribing Program in Homeless Adults Who Use Opiates.
Pietrusza LM; Puskar KR; Ren D; Mitchell AM
J Addict Nurs; 2018; 29(3):188-195. PubMed ID: 30180005
[TBL] [Abstract][Full Text] [Related]
24. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
[TBL] [Abstract][Full Text] [Related]
25. Naloxone acceptance by outpatient veterans: A risk-prioritized telephone outreach event.
Wu S; Frey T; Wenthur CJ
Res Social Adm Pharm; 2021 May; 17(5):1017-1020. PubMed ID: 32980236
[TBL] [Abstract][Full Text] [Related]
26. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA
BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150
[TBL] [Abstract][Full Text] [Related]
27. A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.
Sajwani HS; Williams AV
Harm Reduct J; 2022 Oct; 19(1):117. PubMed ID: 36266701
[TBL] [Abstract][Full Text] [Related]
28. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
[TBL] [Abstract][Full Text] [Related]
29. Piloting a statewide emergency department take-home naloxone program: Improving the quality of care for patients at risk of opioid overdose.
Dora-Laskey A; Kellenberg J; Dahlem CH; English E; Gonzalez Walker M; Brummett CM; Kocher KE
Acad Emerg Med; 2022 Apr; 29(4):442-455. PubMed ID: 34962682
[TBL] [Abstract][Full Text] [Related]
30. Naloxone Telephone Outreach Program in an Outpatient Mental Health Clinic: A Quality Improvement Project.
Huang JN; Gerardi M; Yeargain O; Senterfitt T; Saldiva M
Issues Ment Health Nurs; 2023 Dec; 44(12):1265-1271. PubMed ID: 37883248
[TBL] [Abstract][Full Text] [Related]
31. Local health departments and the implementation of evidence-based policies to address opioid overdose mortality.
Feuerstein-Simon R; Lowenstein M; Sharma M; Dupuis R; Luna Marti X; Cannuscio CC
Subst Abus; 2020; 41(4):468-474. PubMed ID: 32213045
[TBL] [Abstract][Full Text] [Related]
32. Designing a public access naloxone program for public transportation stations.
Kohli S; Garg J; Velasquez DE; Weiner SG
Healthc (Amst); 2023 Jun; 11(2):100694. PubMed ID: 37247465
[TBL] [Abstract][Full Text] [Related]
33. Costs of opioid overdose education and naloxone distribution in New York City.
Behrends CN; Gutkind S; Winkelstein E; Wright M; Dolatshahi J; Welch A; Paone D; Kunins HV; Schackman BR
Subst Abus; 2022; 43(1):692-698. PubMed ID: 34666633
[No Abstract] [Full Text] [Related]
34. Internal Medicine Residents' Feelings of Responsibility, Confidence, and Clinical Practice in Opioid Overdose Prevention and Naloxone Prescribing.
Wang L; Cunningham CO; Browder C; Iyer S
J Addict Med; 2020; 14(5):e147-e152. PubMed ID: 32467412
[TBL] [Abstract][Full Text] [Related]
35. Evaluating equity in community-based naloxone access among racial/ethnic groups in Massachusetts.
Nolen S; Zang X; Chatterjee A; Behrends CN; Green TC; Linas BP; Morgan JR; Murphy SM; Walley AY; Schackman BR; Marshall BDL
Drug Alcohol Depend; 2022 Dec; 241():109668. PubMed ID: 36309001
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of an emergency department-based opioid overdose survivor intervention: Difference-in-difference analysis of electronic health record data to assess key outcomes.
Watson DP; Weathers T; McGuire A; Cohen A; Huynh P; Bowes C; O'Donnell D; Brucker K; Gupta S
Drug Alcohol Depend; 2021 Apr; 221():108595. PubMed ID: 33610095
[TBL] [Abstract][Full Text] [Related]
37. Review of Reported Adverse Events Occurring Among the Homeless Veteran Population in the Veterans Health Administration.
Soncrant C; Mills PD; Pendley Louis RP; Gunnar W
J Patient Saf; 2021 Dec; 17(8):e821-e828. PubMed ID: 34406986
[TBL] [Abstract][Full Text] [Related]
38. Preliminary effectiveness of online opioid overdose and naloxone administration training and impact of naloxone possession on opioid use.
Sisson ML; Azuero A; Chichester KR; Carpenter MJ; Businelle MS; Shelton RC; Cropsey KL
Drug Alcohol Depend; 2023 Aug; 249():110815. PubMed ID: 37336007
[TBL] [Abstract][Full Text] [Related]
39. Characterizing and combating the opioid epidemic in the Los Angeles County jail system.
Tran NT; Muradian IK; Qureshi N; Singh J; Henderson SO
J Subst Use Addict Treat; 2023 Apr; 147():208984. PubMed ID: 36841073
[TBL] [Abstract][Full Text] [Related]
40. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania.
Pizzicato LN; Johnson CC; Viner KM
Subst Abus; 2020; 41(3):301-306. PubMed ID: 31644397
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
